endexxEndexx Corp., based in Phoenix, Arizona, is a company that represents its shareholders’ interest and collaborates with independent scientists, engineers, software developers, and other companies to create businesses that can collectively thrive in equity markets. Endexx Corp., formerly known as Visual Board Books, Inc., is a micro-cap publicly traded company that trades in the OTC market under the symbol EDXC.

Through its subsidiaries—m3Hub, Project Canopy, and Global Solaris Group, Endexx Corp. provides innovative medical marijuana management and technology solutions for entrepreneurs.

The individuals that comprise the Endexx Management Team and its advisory group all have anywhere from 10 to 50 years of experience in their own fields. The business professionals in charge of supervising the company’s direction are all highly knowledgeable in developing and executing new technologies, growing businesses, and operating publicly traded corporations.

The team at Endexx understands that small, independent companies with fresh technologies experience difficulty supporting themselves. They therefore collaborate so as to use both individual and group skill sets to improve technology, grow the business, eliminate redundancies, and consolidate costs simultaneously.

The m3Hub Technology platform manages patient concentric data, integrates the best patient privacy practices through verification, privacy, legal, and transparent controls, and legitimizes the whole transaction process on behalf of the patients.

The Project Canopy platform provides networks with a virtual environment where they can work together, without geographical or physical constraints, by harnessing the power of the cloud.

The Global Solaris Group is a full-service power provider and producer of turnkey Renewable Energy that is professionally engineered for optimal performance for operations that require dependable power systems, such as governments, communities, data centers, schools, churches, electric utilities, irrigation districts, agriculture areas, and mining areas.

Essentially, Endexx Corp. provides as a platform for entrepreneurs to succeed by offering them maximum return on investment via equity ownership in the parent corporation. All individuals are shareholders, and are encouraged to succeed and contribute to the ultimate goal of increasing shareholder value.


Yahoo! Finance: EDXC News

Latest Financial News for EDXC

DJ Khaled Announces "Another One" with his Entrance into The CBD Lifestyle & Wellness Sector

Music magnate, mega producer and GRAMMY® Award-winning artist DJ Khaled announces his entrance into the CBD industry. Inspired by his personal wellness journey, Khaled, in partnership with Endexx Corporation (OTC: EDXC), a leading producer and manufacturer of hemp-derived CBD wellness products, will introduce his new company and debut the first collection in 2021.

Endexx Commends United Nations Landmark Vote to Remove Cannabis from Schedule IV

Endexx Global Operations in Jamaica Ready to Launch  CAVE CREEK, AZ, Dec. 03, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation, (OTC: EDXC) (the “Company” or a/k/a “CBD Unlimited”), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products is pleased to update shareholders on our global expansion plans. In a historic vote in Vienna today, “The United Nations Commission on Narcotic Drugs (CND) accepted a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs.”This World Health Organization recommendation and vote by the UN is the second critical stage to advancing legal changes on cannabis and hemp in all the Industrialized Nations that strictly comply with UN Law. This precedent allows countries like the US, Japan, and Korea to advance new guidelines and laws towards making medicinal cannabis and hemp fully compliant and legal both domestically and globally. As previously mentioned, this ruling opens the potential for banking, insurance, and commodity trading industries to build infrastructure for long-term industry success. Endexx has positioned itself to capitalize directly on this global growth opportunity.CEO of Endexx, Todd Davis, a known pioneer in the industry, had previously predicted this would occur and recently added, “Domino number two, will change the cannabis industry forever. Cannabis, including Hemp, is no longer illegal and considered a dangerous narcotic and worldwide cannabis and CBD markets will exponentially expand the previously predicted market potential by 1000 fold. This promotes the advancement of Hemp and CBD products to become a worldwide accepted commodity and the potential for Endexx brands such as CBD Unlimited, to become a world leader in the marketplace.” “Jamaica Is Endexx’s Global Market Gateway”Endexx through its subsidiary, Go Green Global, has recently received two provisional licenses in Jamaica allowing for the sale, cultivation, processing, and distribution of cannabis upon final approval. Jamaica’s established history with Ganja, now fully legalized, offers a premium agricultural crop and export to unlock the value of its natural resources and globally positioned ports as the gateway for cannabis to the world markets. The UN vote allows Jamaican officials to expedite exportation compliance standards and open the Jamaican cannabis market to the world.  With these new law changes and the massive new market potential, Endexx via Go Green Global can now position itself to quickly move inventory into the European and worldwide markets with a significant lead over potential competitors. Endexx has long been a company known for “Science and Compliance”, with premium quality, and has received strong critical praise.  In addition, CBD Unlimited made significant headway in the industry by showing distribution success establishing real estate in over 6,000 retail stores in the last two years.  Todd Davis added, “This is the big legal “Green Flag” that we have been waiting for and positioned ourselves to take full advantage.  Now, with our Jamaican position, we will further target resources towards both Cannabis and CBD distribution worldwide.”The company has recently positioned itself to expand distribution featuring a new high-quality, lower-price point CBD Unlimited product line. This new initiative accelerates expansion efforts with a value product line to attract a wider consumer base to drive strong international growth. Reference(s):https://news.un.org/en/story/2020/12/1079132https://mjbizdaily.com/united-nations-approves-who-recommendation-to-reschedule-cannabis-in-historic-vote/https://curia.europa.eu/jcms/upload/docs/application/pdf/2020-11/cp200141en.pdfhttps://www.cov.com/en/news-and-insights/insights/2020/11/cjeu-confirms-that-cbd-is-not-a-narcotic-drughttps://www.globenewswire.com/news-release/2020/10/14/2108011/0/en/Endexx-s-International-Division-Go-Green-Global-Announces-Provisional-Approval-for-Two-Licenses-in-Jamaica.htmlAbout Endexx Corporation and CBD UnlimitedEndexx Corporation, through its operating subsidiary CBD Unlimited, Inc., develops and distributes all-natural CBD products derived from the Cannabis Sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work in order to protect the accuracy in dosage and delivery of absorption per each serving.Safe Harbor NoticeThis press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief, or current expectations of the company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.Contact: For further investor and media information, please contact: Endexx Corporation Todd Davis, Chairman, and CEO endexx@endexx.com 480-595-6900

Endexx Applauds Recent Judgement in European Hemp Law

“CBD is a Non-Narcotic”CAVE CREEK, AZ, Nov. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation, (OTC: EDXC) (the “Company” or a/k/a “CBD Unlimited”), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products is pleased to share that in Europe, CBD has just been declared a “non-narcotic substance” by European Court paving the way for world changes and explosive global CBD sales growth.Hemp Industry Daily reports: “European Union’s high court said Thursday that CBD derived from the entire hemp plant is not a narcotic under any international drug treaty and is therefore subject to EU law on the free movement of goods among member states. The landmark interpretation of the 1961 U.N. Single Convention on Narcotic Drugs, handed down by five judges at the EU Court of Justice in Luxembourg, sets a precedent for the regulation of hemp-derived CBD products in Europe and could lead to a shift in how CBD extracts are produced.”Endexx, under its flagship brand, CBD Unlimited, believes this major change will affect Endexx’s global and domestic business enterprise in the following two key ways:1) We have Global Distributors throughout the world ready to distribute our CBD products and with these new industry changes, our product sales are projected to reach a global consumer base and can grow 10-25X current projections.2) We believe the European law ruling will allow the US Congress to advance their new guidance and laws, making CBD fully compliant and legal domestically and globally.  The US interprets European law similarly in approach to standardized agriculture crop policy. This ruling opens the potential for banking, insurance, and commodity trading industries to build infrastructure for long term success. For Endexx, a “Pioneer” and one of the first CBD companies in the market, we believe this to be a watershed moment.  Our shareholders and management will look back on this day as a milestone changing the industry forever. Endexx, CEO, Todd Davis added, “These new changes will enhance our global directive for manufacturing and distribution of finished goods, as well as, expanding opportunities here in the US.  We have positioned ourselves to quickly adapt and take advantage of these rapidly occurring market changes.” Davis added, “this is the first known ruling of CBD from the Whole Hemp plant in regards to the 1961 United Nations Law. Subsequently, all International countries that comply with this law, can now interpret the law in kind.”Reference(s):https://curia.europa.eu/jcms/upload/docs/application/pdf/2020-11/cp200141en.pdfhttps://www.cov.com/en/news-and-insights/insights/2020/11/cjeu-confirms-that-cbd-is-not-a-narcotic-drugAbout Endexx Corporation and CBD Unlimited Endexx Corporation, through its operating subsidiary CBD Unlimited, Inc., develops and distributes all-natural CBD products derived from the Cannabis Sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work in order to protect the accuracy in dosage and delivery of absorption per each serving.Safe Harbor NoticeThis press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief, or current expectations of the company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.Contact: For further investor and media information, please contact: Endexx Corporation Todd Davis, Chairman, and CEO endexx@endexx.com  480-595-6900

Endexx’s Brand CBD Unlimited Continues to Receive Rave Reviews and Market Notoriety

CBD Unlimited is quickly rising to become the highest quality known brand in CBD. Cave Creek, AZ, Nov. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Endexx Corporation, (OTC: EDXC) (the “Company” or a/k/a “CBD Unlimited”), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, is pleased to share that it has recently been garnering press and attention for its high-quality brand of products.  Some recent examples include: * CBD NERDS: In an unusual move, well known CBDNerds’ website published high praise for CBD Unlimited products but went further to endorse the company as a solid stock buy.  Read more here: https://www.thecbdnerds.com/post/what-is-cbd-unlimited-and-why-should-you-know-about-it * CBD Life Magazine: CBD Magazine made a full review of CBD Unlimited products:https://cbdlifemag.com/a-full-review-of-cbd-unlimited-premium-blue-range-products/?fbclid=IwAR2OSl9YmtOSIfvQryyM3Oc9bKGBtsOINTCa-jlfU6gp64fhADoG2S7dE0c * Edge Media: Edge Media Network has recently published two articles about CBD Unlimited highlighting both the high quality as well as guidance to using CBD products featuring our CEO, Todd Davis:https://www.edgemedianetwork.com/story.php?ch=health_fitness&sc=health&id=298874&how_much_is_enough and;https://www.edgemedianetwork.com/story.php?ch=health_fitness&sc=health&sc2=&id=298873&fbclid=IwAR1hKm247xpSSjQlLyru4F3YQsRs3Fz8E56O_KuxFpoAtFxE2pleOeDnsVw * MERRY JANE: A well-known Marijuana and CBD website endorsing CBD Unlimited tinctures.    https://merryjane.com/culture/just-a-few-drops-here-are-the-top-10-cannabis-tinctures-on-the-market-right-now?fbclid=iwar0iwe8nyaqxqf2kgfmnohfoxcffiu_id8eatwvebv7omicwhidasb0zv1iMore can be found by searching “CBD Unlimited” on the web.  With so much recent news and development in the cannabis world, CBD is becoming a major worldwide highlight as more states and countries continue to legalize cannabis in all forms. CBD Unlimited has quickly become a name brand for trusted quality products found in over 6,000 retail stores and growing. CBD Unlimited is part of the publicly-traded company, Endexx.  Endexx CEO and Chairman, Todd Davis, commented, “We would like to thank our current shareholders for their continued support as the Company has been able to flourish over the years.  We are excited for the future of CBD Unlimited and appreciate the recent third party attention and positive reviews our products have received.”About Endexx Corporation and CBD UnlimitedEndexx Corporation, through its operating subsidiary CBD Unlimited, Inc., develops and distributes all-natural CBD products derived from Cannabis Sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work in order to protect the accuracy in dosage and delivery of absorption per each serving.Safe Harbor NoticeThis press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.Contact:For further investor and media information, please contact:Endexx CorporationTodd Davis, Chairman, and CEOendexx@endexx.com480-595-6900

Endexx Files Application and Certification for OTCQB Venture Market

CAVE CREEK, AZ , Nov. 10, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTCQB: EDXC), also known as CBD Unlimited Inc., a provider of innovative phytonutrient-based food and nutritional products, has filed its OTCQB Certification and application documents with OTC Markets seeking to up list and commence trading on the OTCQB® Venture Market under the symbol EDXC.The OTCQB Venture market operated by OTC Markets Group, Inc. in New York City is a verified, premier market destination for developing and early stage companies. The OTCQB Venture Market provides investors with efficient access to companies which will help continue to grow Endexx’s shareholder base while building shareholder value. Endexx  is fully compliant, current in its Audited financial filings and has undergone an annual company verification and management certification process. About EndexxEndexx Corporation through its subsidiary, CBD Unlimited Inc., develops and distributes all-natural CBD products derived from cannabis sativa-L plant (Hemp), containing less than 0.01% THC. Its products range from analgesics, oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving. Websites: www.endexx.com and  www.cbdunlimited.com  Safe Harbor NoticeThis press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.Contact:  For further investor and media information, contact: Endexx Corporation Todd Davis Chairman & CEOendexx@endexx.com 480-595-6900